Published Online:https://doi.org/10.1148/rg.306105513

Recent advances in knowledge about the genetics, pathophysiology, and molecular biology of renal cystic diseases in adults are reviewed, and the implications of specific imaging findings for the diagnosis and management of these diseases are explored.

Renal cystic diseases in adults are a heterogeneous group of disorders characterized by the presence of multiple cysts in the kidneys. These diseases may be categorized as hereditary, acquired, or developmental on the basis of their pathogenesis. Hereditary conditions include autosomal dominant polycystic kidney disease, medullary cystic kidney disease, von Hippel-Lindau disease, and tuberous sclerosis. Acquired conditions include cystic kidney disease, which develops in patients with end-stage renal disease. Developmental cystic diseases of the adult kidney include localized renal cystic disease, multicystic dysplastic kidney, and medullary sponge kidney. In recent years, many molecular and cellular mechanisms involved in the pathogenesis of renal cystic diseases have been identified. Hereditary renal cystic diseases are characterized by genetic mutations that lead to defects in the structure and function of the primary cilia of renal tubular epithelial cells, abnormal proliferation of tubular epithelium, and increased fluid secretion, all of which ultimately result in the development of renal cysts. A better understanding of these pathophysiologic mechanisms is now providing the basis for the development of more targeted therapeutic drugs for some of these disorders. Cross-sectional imaging provides useful information for diagnosis, surveillance, prognostication, and evaluation of treatment response in renal cystic diseases.

© RSNA, 2010

References

  • 1 Bisgrove BW, Yost HJ. The roles of cilia in developmental disorders and disease. Development 2006; 133(21):4131–4143. Crossref, MedlineGoogle Scholar
  • 2 Rodat-Despoix L, Delmas P. Ciliar functions in the nephron. Pflugers Arch 2009;458(1):179–187. Crossref, MedlineGoogle Scholar
  • 3 Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol 2007;8(11):880–893. Crossref, MedlineGoogle Scholar
  • 4 Zhang Q, Taulman PD, Yoder BK. Cystic kidney diseases: all roads lead to the cilium. Physiology (Bethesda) 2004;19:225–230. Crossref, MedlineGoogle Scholar
  • 5 Truong LD, Choi YJ, Shen SS, Ayala G, Amato R, Krishnan B. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol 2003;10(3):135–159. Crossref, MedlineGoogle Scholar
  • 6 Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008;359(14):1477–1485. Crossref, MedlineGoogle Scholar
  • 7 Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A. Renal cystic diseases: a review. Adv Anat Pathol 2006;13(1):26–56. Crossref, MedlineGoogle Scholar
  • 8 Wilson PD, Goilav B. Cystic disease of the kidney. Annu Rev Pathol 2007;2:341–368. Crossref, MedlineGoogle Scholar
  • 9 Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci USA 1971 Apr:68(4): 820–823. Crossref, MedlineGoogle Scholar
  • 10 Choyke PL. Inherited cystic diseases of the kidney. Radiol Clin North Am 1996;34(5):925–946. MedlineGoogle Scholar
  • 11 Chapman AB. Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. Clin J Am Soc Nephrol 2008;3(4):1197–1204. Crossref, MedlineGoogle Scholar
  • 12 Grantham JJ, Torres VE, Chapman AB, et al.. Volume progression in polycystic kidney disease. N Engl J Med 2006;354(20):2122–2130. Crossref, MedlineGoogle Scholar
  • 13 Bae KT, Grantham JJ. Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol 2010;6(2):96–106. Crossref, MedlineGoogle Scholar
  • 14 Grantham JJ, Chapman AB, Torres VE. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 2006;1(1):148–157. Crossref, MedlineGoogle Scholar
  • 15 Torres VE, King BF, Chapman AB, et al.. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007;2(1):112–120. Crossref, MedlineGoogle Scholar
  • 16 Hildebrandt F, Otto E. Molecular genetics of nephronophthisis and medullary cystic kidney disease. J Am Soc Nephrol 2000;11(9):1753–1761. Crossref, MedlineGoogle Scholar
  • 17 Adams M, Smith UM, Logan CV, Johnson CA. Recent advances in the molecular pathology, cell biology and genetics of ciliopathies. J Med Genet 2008;45(5):257–267. Crossref, MedlineGoogle Scholar
  • 18 Hildebrandt F, Attanasio M, Otto E. Nephron-ophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol 2009;20(1):23–35. Crossref, MedlineGoogle Scholar
  • 19 Rizk D, Chapman AB. Cystic and inherited kidney diseases. Am J Kidney Dis 2003;42(6):1305–1317. Crossref, MedlineGoogle Scholar
  • 20 Meier P, Farres MT, Mougenot B, et al.. Imaging medullary cystic kidney disease with magnetic resonance. Am J Kidney Dis 2003;42(1):E5–E10. Crossref, MedlineGoogle Scholar
  • 21 Wise SW, Hartman DS, Hardesty LA, Mosher TJ. Renal medullary cystic disease: assessment by MRI. Abdom Imaging 1998;23(6):649–651. Crossref, MedlineGoogle Scholar
  • 22 Scolari F, Viola BF, Prati E, et al.. Medullary cystic kidney disease: past and present. Contrib Nephrol 2001;(136):68–78. Crossref, MedlineGoogle Scholar
  • 23 Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H. Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 2008;15(3):165–171. Crossref, MedlineGoogle Scholar
  • 24 Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. Von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995;194(3):629–642. LinkGoogle Scholar
  • 25 Leung RS, Biswas SV, Duncan M, Rankin S. Imaging features of von Hippel-Lindau disease. RadioGraphics 2008;28(1):65–79. LinkGoogle Scholar
  • 26 Shuin T, Yamazaki I, Tamura K, Kamada M, Ashida S. Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease. Int J Clin Oncol 2004;9(4):283–287. Crossref, MedlineGoogle Scholar
  • 27 Kuehn EW, Walz G, Benzing T. Von Hippel-Lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development. Cancer Res 2007;67(10):4537–4540. Crossref, MedlineGoogle Scholar
  • 28 Wiesener MS, Maxwell PH, Eckardt KU. Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression. J Mol Med 2009;87(9):871–877. Crossref, MedlineGoogle Scholar
  • 29 Choudhary S, Sudarshan S, Choyke PL, Prasad SR. Renal cell carcinoma: recent advances in genetics and imaging. Semin Ultrasound CT MR 2009;30(4):315–325. Crossref, MedlineGoogle Scholar
  • 30 Choyke PL, Glenn GM, Walther MM, et al.. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 1992;159(6):1229–1234. Crossref, MedlineGoogle Scholar
  • 31 Meister M, Choyke P, Anderson C, Patel U. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol 2009;64(6):589–600. Crossref, MedlineGoogle Scholar
  • 32 Narayanan V. Tuberous sclerosis complex: genetics to pathogenesis. Pediatr Neurol 2003;29(5):404–409. Crossref, MedlineGoogle Scholar
  • 33 Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int 2006;70(10):1777–1782. Crossref, MedlineGoogle Scholar
  • 34 Umeoka S, Koyama T, Miki Y, Akai M, Tsutsui K, Togashi K. Pictorial review of tuberous sclerosis in various organs. RadioGraphics 2008;28(7):e32. Google Scholar
  • 35 Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med 2006;355(13):1345–1356. Crossref, MedlineGoogle Scholar
  • 36 Bonnet CS, Aldred M, von Ruhland C, Harris R, Sandford R, Cheadle JP. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis. Hum Mol Genet 2009;18(12):2166–2176. Crossref, MedlineGoogle Scholar
  • 37 Hartman TR, Liu D, Zilfou JT, et al.. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 2009;18(1):151–163. Crossref, MedlineGoogle Scholar
  • 38 Martignoni G, Bonetti F, Pea M, Tardanico R, Brunelli M, Eble JN. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. Am J Surg Pathol 2002;26(2):198–205. Crossref, MedlineGoogle Scholar
  • 39 Casper KA, Donnelly LF, Chen B, Bissler JJ. Tuberous sclerosis complex: renal imaging findings. Radiology 2002;225(2):451–456. LinkGoogle Scholar
  • 40 Pompili G, Zirpoli S, Sala C, et al.. Magnetic resonance imaging of renal involvement in genetically studied patients with tuberous sclerosis complex. Eur J Radiol 2009;72(2):335–341. Crossref, MedlineGoogle Scholar
  • 41 Choyke PL. Acquired cystic kidney disease. Eur Radiol 2000;10(11):1716–1721. Crossref, MedlineGoogle Scholar
  • 42 Grantham JJ. Acquired cystic kidney disease. Kidney Int 1991;40(1):143–152. Crossref, MedlineGoogle Scholar
  • 43 Levine E. Acquired cystic kidney disease. Radiol Clin North Am 1996;34(5):947–964. MedlineGoogle Scholar
  • 44 Tickoo SK, dePeralta-Venturina MN, Harik LR, et al.. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006;30(2):141–153. Crossref, MedlineGoogle Scholar
  • 45 Gambaro G, Feltrin GP, Lupo A, Bonfante L, D'Angelo A, Antonello A. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int 2006;69(4):663–670. Crossref, MedlineGoogle Scholar
  • 46 Mayall GF. The incidence of medullary sponge kidney. Clin Radiol 1970;21(2):171–174. Crossref, MedlineGoogle Scholar
  • 47 Maw AM, Megibow AJ, Grasso M, Goldfarb DS. Diagnosis of medullary sponge kidney by computed tomographic urography. Am J Kidney Dis 2007;50(1):146–150. Crossref, MedlineGoogle Scholar
  • 48 Klemme L, Fish AJ, Rich S, Greenberg B, Senske B, Segall M. Familial ureteral abnormalities syndrome: genomic mapping, clinical findings. Pediatr Nephrol 1998;12(5):349–356. Crossref, MedlineGoogle Scholar
  • 49 Gambaro G, Fabris A, Citron L, et al.. An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. Nephrol Dial Transplant 2005;20(6):1042–1047. Crossref, MedlineGoogle Scholar
  • 50 Rommel D, Pirson Y. Medullary sponge kidney—part of a congenital syndrome. Nephrol Dial Transplant 2001;16(3):634–636. Crossref, MedlineGoogle Scholar
  • 51 Prasad SR, Narra VR, Shah R, et al.. Segmental disorders of the nephron: histopathological and imaging perspective. Br J Radiol 2007;80(956):593–602. Crossref, MedlineGoogle Scholar
  • 52 Lang EK, Thomas R, Davis R, et al.. Multiphasic helical computerized tomography for the assessment of microscopic hematuria: a prospective study. J Urol 2004;171(1):237–243. Crossref, MedlineGoogle Scholar
  • 53 Lang EK, Macchia RJ, Thomas R, et al.. Improved detection of renal pathologic features on multiphasic helical CT compared with IVU in patients presenting with microscopic hematuria. Urology 2003;61(3):528–532. Crossref, MedlineGoogle Scholar
  • 54 Levine E, Hartman DS, Meilstrup JW, Van Slyke MA, Edgar KA, Barth JC. Current concepts and controversies in imaging of renal cystic diseases. Urol Clin North Am 1997;24(3):523–543. Crossref, MedlineGoogle Scholar
  • 55 Pope JC, Brock JW, Adams MC, Stephens FD, Ichikawa I. How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 1999;10(9):2018–2028. Crossref, MedlineGoogle Scholar
  • 56 Watanabe T, Yamazaki A, Kurabayashi T, Hanaoka J. Familial multicystic dysplastic kidney. Pediatr Nephrol 2005;20(8):1200. Crossref, MedlineGoogle Scholar
  • 57 Jeon A, Cramer BC, Walsh E, Pushpanathan C. A spectrum of segmental multicystic renal dysplasia. Pediatr Radiol 1999;29(5):309–315. Crossref, MedlineGoogle Scholar
  • 58 Rabêlo EA, Oliveira EA, Silva JM, et al.. Conservative management of multicystic dysplastic kidney: clinical course and ultrasound outcome [in Portuguese]. J Pediatr (Rio J) 2005;81(5):400–404. Crossref, MedlineGoogle Scholar
  • 59 Bisceglia M, Cretì G. AMR series unilateral (localized) renal cystic disease. Adv Anat Pathol 2005;12(4):227–232. Crossref, MedlineGoogle Scholar
  • 60 Slywotzky CM, Bosniak MA. Localized cystic disease of the kidney. AJR Am J Roentgenol 2001;176(4):843–849. Crossref, MedlineGoogle Scholar
  • 61 Kim DJ, Kim MJ. Localized cystic disease of the kidney: CT findings. Abdom Imaging 2003;28(4):588–592. Crossref, MedlineGoogle Scholar
  • 62 Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. RadioGraphics 2008;28(5):1325–1338. LinkGoogle Scholar
  • 63 Chang MY, Ong AC. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment. Nephron Physiol 2008;108(1):p1–p7. Crossref, MedlineGoogle Scholar

Article History

Received: Feb 4 2010
Revision requested: Mar 2 2010
Revision received: Apr 13 2010
Accepted: Apr 20 2010
Published online: Oct 6 2010
Published in print: Oct 2010